Recent News & Media
-
 copy.jpg)
The Byers Eye Institute is proud to offer the only FDA-approved treatment for patients diagnosed with macular telangiectasia type 2, known as MacTel. Make an appointment at: 650.723.6995. No center has implanted more of these devices in patients.
-
Eye prosthesis is the first to restore sight lost to macular degeneration
In a Stanford Medicine-led clinical trial of a wireless retinal prosthesis, people with advanced macular degeneration regained enough vision to read books and subway signs.
-
First FDA-approved MacTel treatment available at the Byers Eye Institute
The Byers Eye Institute is proud to offer the only FDA-approved treatment for patients diagnosed with macular telangiectasia type 2, known as MacTel. Make an appointment at: 650.723.6995. No center has implanted more of these devices in patients.
-
Unraveling mysteries of human behavior
Andreas Tolias, PhD, was named a primary investigator in 10-year project to shed new light on human behavior and cognition…
-
Bridging the data gap in pediatric ophthalmology
A Byers Eye Institute-led team was awarded to map eye exam data and harness it for clinical research.
-
AI models of the brain could serve as ‘digital twins’ in research
In a new study, researchers created an AI model of the mouse visual cortex that predicts neuronal responses to visual images.
-
Kuldev Singh, MD, MPH, on Cataract Coach
Kuldev Singh, MD, MPH, as been an ophthalmologist at Stanford University for more than three decades and is a recognized expert in glaucoma clinical care.
-
New research uncovers promising treatment for neurodegenerative diseases like ALS, glaucoma
The treatment approach targets diseases that cause degeneration of the axons in the central nervous system.
-
Hewlett Award Winner Mark S. Blumenkranz, MD, MMS: “I love what I do. It’s like a dream.”
The Albion Walter Hewlett Award is a Department of Medicine-sponsored award honoring an exceptional physician with ties to Stanford.
-
Direct-to-consumer genetic database used to identify AMD variants
CHICAGO — Researchers used a direct-to-consumer genetic testing service to identify patients with CFH Y402H and ARMS2 A69S alleles, the genetic variants most commonly associated with an increased risk for developing age-related macular degeneration, a speaker said here.
-
SOAR resident receives grant from Knights Templar Eye Foundation to support retina research
Luciano Custo Greig, MD, PhD, a current trainee in the Stanford Ophthalmology Advanced Research (SOAR) Residency Program, is the recipient of a Career Starter Grant from the Knights Templar Eye Foundation for his research on regeneration of retinal ganglion cells from endogenous progenitors.
-
Precision Medicine Will Rely on Proteins, Not Just DNA
Like an oasis in the desert, the splendor of precision medicine seems perpetually on the horizon. Even as technological advances bring genome sequencing into routine clinical use, it’s becoming clearer than ever that genomics reveals only part of the clinical picture.
-
-
Ophthalmology Department hosting second annual Ocular Melanoma Benefit 5K Fun Run and Walk
Want a chance to race through the beautiful Baylands, all while honoring a great cause? On Sunday, May 19, the Byers Eye Institute will host the second annual “Lookin’ for a Cure Ocular Melanoma Benefit 5K Fun Run and Walk.”…
-
American Academy of Ophthalmology highlights Singh’s expertise on glaucoma surgery
Following his recent presentation at Glaucoma 360, Kuldev Singh, MD, MPH, professor of ophthalmology and director of the glaucoma service, was interviewed on the relevancy of trabeculectomy with the rising popularity of minimally invasive glaucoma surgery (MIGS).
-
Palanker’s invention leads to restoration of vision in patients with age-related macular degeneration
Daniel Palanker, PhD, professor of ophthalmology and director of the Hansen Experimental Physics Laboratory, developed a photovoltaic retinal prosthesis for restoring sight in retinal degeneration. This technology has been commercialized through a partnership with Pixium Vision (Paris, France), and the product is called “PRIMA Bionic Vision System”.
-
Vision-restoring whole eye transplants may soon be a reality
More than 40 scientists, doctors, and industry experts hand-picked from around the country are joining together to make whole eye transplants a reality.
-
Inception Insights
The research that Andreas Tolias, PhD, does in his laboratory is undeniably futuristic, even by Silicon Valley standards. That is why when he took up his post as professor of ophthalmology at the Byers Eye Institute in April 2024, the feeling across the university was one of elation.
-
2024 Letter From the Chair
I am sure I say this every year, but 2024 marked the most exciting year to-date at the Byers Eye Institute, as the research and clinical advances we made have once again set a high bar to top in the future.
-
Finding a Purpose
When Stacy Miller found herself couch-bound for months after a head injury in 2015, she kept herself busy with books. At first, she was just following her neurologist’s advice to keep her brain active, but soon it was more than that.
